Diffuse Midline Glioma, H3 K27M-Mutant

27 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Diffuse Midline Glioma, H3 K27M-Mutant

Record	Firm	Date
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG (NCT04943848)	Ann & Robert H Lurie Children's Hospital of Chicago	2022-01-10
Combination Therapy for the Treatment of Diffuse Midline Gliomas (NCT05009992)	University of California, San Francisco	2021-10-20
Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial (NCT05077735)	Mayo Clinic	2021-10-11
Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) (NCT04804709)	Columbia University	2021-07-28
A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) (NCT04771897)	Bexion Pharmaceuticals, Inc.	2021-05-24
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms (NCT04541082)	Jazz Pharmaceuticals	2020-10-26
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas (NCT02960230)	Sabine Mueller, MD, PhD	2016-11-18
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas (NCT01922076)	National Cancer Institute (NCI)	2013-09-03
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository (NCT03101813)	Children's Hospital Medical Center, Cincinnati	2012-06-01
Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered (NCT05518838)	Oblato, Inc.

Track Diffuse Midline Glioma, H3 K27M-Mutant automatically

Every clearance here is in the API, with alerts when new ones post.